封面
市場調查報告書
商品編碼
1490024

預防性醫療技術和服務的全球市場:按服務類型、按技術類型、按最終用戶、按地區

Global Preventive Healthcare Technologies And Services Market, By Service Type, By Technology Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年,全球預防保健技術和服務市場價值將達到2,752.9億美元,預計2031年將達到5,566.4億美元,2024年至2031年年複合成長率為10.6%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 2752.9億美元
實際資料 2019-2023 預測期 2024-2031
預測期:2024-2031年年複合成長率: 10.60% 2031 年金額預測 5566.4億美元
圖:2024 年按地區分類的預防性醫療技術和服務的全球市場佔有率(%)
全球預防保健技術與服務市場-IMG1

近年來,全球預防保健技術和服務市場經歷了顯著成長。預防性醫療保健旨在預防疾病、病症和傷害並促進身體健康。科技的進步和對人口健康管理日益濃厚的興趣正在擴大預防醫學的範圍。診斷影像、先進生物標記和遺傳學等各種技術使得早期發現疾病和評估風險成為可能。此外,數位健康解決方案的普及支持遠端監控並促進獲得預防服務。隨著世界各地慢性病的盛行率增加,對預防干涉措施的需求呈指數級成長。這促使投資開發創新的預防性醫療保健模式和干涉措施。隨著人們對預防的日益重視,預計該市場在未來幾年將顯著成長。

市場動態:

與文明病盛行率不斷上升,越來越多的老年人更容易患上慢性病,以及與治療相關的醫療費用的增加,正在推動對預防性醫療技術和服務的需求。針對公共衛生的各種政府計劃也在推動這些解決方案的採用。然而,先進預防醫療技術和服務的部署因所需的大量投資而受到阻礙。開拓負擔得起的預防解決方案對於市場開拓來說是一個機會。整合人工智慧等最尖端科技也有可能徹底改變預防性醫療保健。

本研究的主要特點

  • 該報告對全球預防保健技術和服務市場進行了詳細分析,並列出了以2023年為基準年的預測期(2024-2031年)的市場規模和年複合成長率(CAGR%)。
  • 它還強調了各個細分市場的潛在收益成長機會,並說明了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 根據公司亮點、產品系列、主要亮點、績效和策略等參數,提供全球預防保健技術和服務市場中主要企業的概況。
  • 主要企業包括Healthlane、Abbott、GSK plc、Myriad Genetics、Omron Healthcare Inc.、Quest Diagnostics、Pfizer, Inc.、Merck &Co., Inc.、Omnicell、Novx Systems, Corp.、U-Systems, Ltd.。 Viatronix , Inc.、Scripto LLC、Lifecom, Inc.、Dilon Medical Technologies, Inc. 和 McKesson Corporation。
  • 從這份報告中獲得的見解將使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球預防保健技術和服務市場迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 透過用於分析全球預防保健技術和服務市場的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 收購和合作場景
  • 產品發布/核准
  • 品牌及價格分析
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章全球預防性醫療保健技術與服務市場-冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章全球預防保健技術與服務市場,依服務類型,2019-2031

  • 診斷服務
  • 健康/健康評估服務
  • 遠端醫療服務
  • 藥局服務
  • 其他

第6章全球預防保健技術與服務市場,依技術類型,2019-2031

  • 遠端醫療
  • 行動醫療
  • 醫療資訊技術
  • 穿戴式裝置
  • 其他

第 7 章 全球預防保健技術與服務市場,依最終使用者分類,2019-2031 年

  • 醫療服務提供方
  • 醫療保健付款人
  • 其他

第8章全球預防醫療技術和服務市場,按地區,2019-2031

第9章 競爭格局

  • 公司簡介
    • Healthlane
    • Abbott
    • GSK plc
    • Myriad Genetics
    • Omron Healthcare Inc.
    • Quest Diagnostics
    • Pfizer, Inc.
    • Merck &Co., Inc.
    • Omnicell
    • Novx Systems, Corp.
    • U-Systems, Ltd.
    • Viatronix, Inc.
    • Scripto LLC
    • Lifecom, Inc.
    • Dilon Medical Technologies, Inc.
    • McKesson Corporation

第10章分析師的觀點

  • 命運之輪
  • 分析師觀點
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI6961

The global preventive healthcare technologies and services market is estimated to be valued at USD 275.29 Bn in 2024 and is expected to reach USD 556.64 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 275.29 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 10.60% 2031 Value Projection: US$ 556.64 Bn
Figure. Global Preventive Healthcare Technologies And Services Market Share (%), By Region 2024
Global Preventive Healthcare Technologies And Services Market - IMG1

The global preventive healthcare technologies and services market has been witnessing significant growth in recent years. Preventive healthcare aims to prevent diseases, conditions or injuries and promote good health. Advancements in technologies and growing focus on population health management have expanded the scope of preventive care. Various technologies such as imaging, advanced biomarkers, and genetics have enabled early detection and risk assessment of diseases. In addition, the widespread adoption of digital health solutions is supporting remote monitoring and facilitating access to preventive services. As the prevalence of chronic diseases rises worldwide, the demand for preventive interventions is growing exponentially. This has prompted investments into the development of innovative preventive healthcare models and measures. The market is expected to grow substantially in the coming years as focus on prevention gains more prominence.

Market Dynamics:

Rising incidence of lifestyle diseases, growing geriatric population susceptible to chronic illnesses and increasing healthcare costs associated with treatment are driving the demand for preventive healthcare technologies and services. Various government programmes aimed at population health are also boosting the adoption of these solutions. However, high investment requirements for the deployment of advanced preventive technologies and services act as a restraint. Developing affordable preventive solutions represents an opportunity for market players. Integrating cutting-edge technologies, such as artificial intelligence, also holds potential to revolutionize preventive care.

Key Features of the Study:

  • This report provides an in-depth analysis of the global preventive healthcare technologies and services market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global preventive healthcare technologies and services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Healthlane, Abbott , GSK plc, Myriad Genetics, Omron Healthcare Inc., Quest Diagnostics, Pfizer, Inc., Merck & Co., Inc., Omnicell , Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., Scripto LLC , Lifecom, Inc., Dilon Medical Technologies, Inc., and McKesson Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global preventive healthcare technologies and services market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive healthcare technologies and services market.

Detailed Segmentation-

  • By Service Type:
    • Diagnostic Services
    • Wellness & Health Assessment Services
    • Telemedicine Services
    • Pharmacy Services
    • Others
  • By Technology Type:
    • Telemedicine
    • mHealth
    • Health Information Technology
    • Wearable Devices
    • Others
  • By End User:
    • Healthcare Providers
    • Healthcare Payers
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Healthlane
    • Abbott
    • GSK plc
    • Myriad Genetics
    • Omron Healthcare Inc.
    • Quest Diagnostics
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • Omnicell
    • Novx Systems, Corp.
    • U-Systems, Ltd.
    • Viatronix, Inc.
    • Scripto LLC
    • Lifecom, Inc.
    • Dilon Medical Technologies, Inc.
    • McKesson Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By Technology Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Brand and Pricing Analysis
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Preventive Healthcare Technologies And Services Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Preventive Healthcare Technologies And Services Market, By Service Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Diagnostic Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Wellness & Health Assessment Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Telemedicine Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pharmacy Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Preventive Healthcare Technologies And Services Market, By Technology Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Telemedicine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • mHealth
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Health Information Technology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Wearable Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Preventive Healthcare Technologies And Services Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Healthcare Providers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Healthcare Payers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Preventive Healthcare Technologies And Services Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Healthlane
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott
    • GSK plc
    • Myriad Genetics
    • Omron Healthcare Inc.
    • Quest Diagnostics
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • Omnicell
    • Novx Systems, Corp.
    • U-Systems, Ltd.
    • Viatronix, Inc.
    • Scripto LLC
    • Lifecom, Inc.
    • Dilon Medical Technologies, Inc.
    • McKesson Corporation

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact